PON1 ELISA试剂盒

Zaragoza-García, Guzmán-Guzmán, Moreno-Godínez, Navarro-Zarza, Antonio-Vejar, Ramírez, Parra-Rojas: "PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients." in: Clinical rheumatology, Vol. 40, Issue 2, pp. 741-752, (2021) (PubMed).

Wang, Liu, Zhong, Yang, Yang, Covaci, Zhu: "Estimating renal and hepatic clearance rates of organophosphate esters in humans: Impacts of intrinsic metabolism and binding affinity with plasma proteins." in: Environment international, Vol. 134, pp. 105321, (2020) (PubMed).

Lioudaki, Verikokos, Kouraklis, Kontopodis, Markakis, Ioannou, Daskalopoulou, Perrea, Klonaris: "Paraoxonase-1 and Symptomatic Status in Carotid Artery Disease." in: Annals of vascular surgery, Vol. 64, pp. 355-360, (2020) (PubMed).

Ahmed: "Correlation of Paraoxonase-1 with glycated hemoglobin and lipid profile among Sudanese diabetic patients." in: Pakistan journal of medical sciences, Vol. 35, Issue 4, pp. 1050-1054, (2019) (PubMed).

Ogłodek: "The role of PON-1, GR, IL-18, and OxLDL in depression with and without posttraumatic stress disorder." in: Pharmacological reports : PR, Vol. 69, Issue 5, pp. 837-845, (2018) (PubMed).

Pop, Niculae, Pop, Răchișan: "Individuals with autism have higher 8-Iso-PGF2α levels than controls, but no correlation with quantitative assay of Paraoxonase 1 serum levels." in: Metabolic brain disease, Vol. 32, Issue 6, pp. 1943-1950, (2018) (PubMed).

Crow, Meek, Wills, Chambers: "A case-control study: The association of serum paraoxonase 1 activity and concentration with the development of type 2 diabetes mellitus." in: Diabetes/metabolism research and reviews, Vol. 34, Issue 3, (2018) (PubMed).

Singh, Singh, Chandra, Tyagi: "Paraoxonase-1 is a better indicator than HDL of Atherosclerosis - A pilot study in North Indian population." in: Diabetes & metabolic syndrome, Vol. 12, Issue 3, pp. 275-278, (2018) (PubMed).

Samouilidou, Bountou, Papandroulaki, Papamanolis, Papakostas, Grapsa: "Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease." in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, Vol. 22, Issue 4, pp. 325-331, (2018) (PubMed).

Samouilidou, Kostopoulos, Liaouri, Kioussi, Vassiliou, Bountou, Grapsa: "Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease." in: Renal failure, pp. 1-6, (2016) (PubMed).